Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06178445 |
| Title | Efficacy and Safety of GemCis Plus Trastuzumab Plus Pembrolizumab in Previously Untreated HER2-positive Biliary Tract Cancer (TRAP-BTC) |
| Acronym | TRAP-BTC |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Institut fur Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | DEU |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Universitätsklinikum Augsburg | Augsburg | Germany | Details | |||
| Charité Universitätsmedizin | Berlin | Germany | Details | |||
| Krankenhaus Nordwest (KHNW) | Frankfurt | Germany | Details | |||
| Universitätsklinikum Freiburg | Freiburg im Breisgau | Germany | Details | |||
| Universitätsklinikum Göttingen | Göttingen | Germany | Details | |||
| Hämatologisch-Onkologische Praxis Eppendorf (HOPE) | Hamburg | Germany | Details | |||
| Medizinische Hochschule Hannover | Hanover | Germany | Details | |||
| LMU München | München | Germany | Details |